News | Proton Therapy | May 01, 2019

Pencil Beam Scanning Better Protects Children With Brain Tumors

Comparative study finds precise form of proton therapy delivers lowest dose to temporal lobes and hippocampus

Pencil Beam Scanning Better Protects Children With Brain Tumors

May 1, 2019 — A comparison of three types of radiotherapy for children's brain tumors suggests a type of proton therapy called pencil beam scanning (PBS) offers the best hope of preserving cognitive functions. The study, presented at the European Society for Radiotherapy and Oncology (ESTRO) 38 conference April 26-30 in Milan, Italy, shows this new form of radiotherapy delivers the lowest doses of radiation to the temporal lobes and hippocampus, areas of the brain important in functions like memory.

The study was presented by Laura Toussaint, a Ph.D. student at the department of Medical Physics, Aarhus University Hospital, Denmark. She said, "Brain tumors are the second most common type of cancer in children. Survival rates have increased in recent decades and currently 75 percent of children diagnosed with a brain tumor will be alive five years later.

"Alongside surgery and chemotherapy, radiotherapy plays an important role in treating brain tumors in children, but we need to protect children's developing brains from any unnecessary radiation. The more we learn about how to effectively target brain tumors while minimizing the dose to other parts of the brain, the better we can preserve children's cognitive abilities and quality of life after treatment."

Toussaint and her colleagues carried out detailed studies of 10 different children treated for brain tumors. Each child had been diagnosed with a type of cancer called craniopharyngioma, centrally located in their brain.

For each child, they planned treatments with each of the three types of radiotherapy: volumetric modulated arc therapy (VMAT), double scattering proton therapy (DSPT) or PBS proton therapy. All three are advanced radiotherapy treatments but DSPT and PBS are both types of proton therapy, which research suggests is better at targeting the tumor more precisely while sparing the surrounding tissues. However, they require expensive specific equipment that is not yet available in all hospitals. PBS is an especially precise form of radiotherapy that delivers treatment via a very narrow proton beam.

Previous research has shown that radiation doses to particular areas of the brain, including the temporal lobes and hippocampus, have an impact on children's cognitive outcomes, specifically in memory functions. Toussaint and her colleagues used these existing data to select 30 structures in the children's brains to study.

The researchers used computed tomography (CT) and magnetic resonance imaging (MRI) scans to precisely locate the structures in each of the children's brains. Then they compared the three treatment plans for each child to see which type of treatment was better at sparing those 30 structures from radiation, categorizing the dose to each structure as high, medium or low.

They found the doses to the temporal lobe were lower with the PBS treatment, compared to both the DSPT and VMAT treatments.

They found, for example, that 41 percent of the left hippocampus volume was receiving low doses of radiation with the DSPT plans, while being spared with the PBS treatment.

Using the existing data on the impacts of radiation to these regions of the brain, the researchers predict that the proton therapies, particularly the PBS treatment, would result in less impairment of the children's memory function.

Toussaint said, "We have looked at three types of radiotherapy, which all aim to successfully treat brain tumors while doing as little damage to children's brains as possible. What we found was that pencil beam scanning proton therapy seems to be by far the best at avoiding parts of the brain that are important in children's memory. The next step would be to confirm this finding with clinical research in patients.

"The use of proton therapy has been expanding rapidly over the last decade and is becoming more and more available for cancer patients, especially for children. This also means that more research can take place."

There are around 25 proton therapy centers operating in Europe, and another 19 are under construction or planned.

Prof. Umberto Ricardi, president of ESTRO and head of the Department of Oncology at the University of Turin, Italy, who was not involved in the research, said, "The aim of radiotherapy is to effectively treat cancer while causing as little damage as possible to the rest of the body. This aim could not be more important than when we are treating children's brains. Proton therapy is already being used in some hospitals to treat brain tumors in children, but this study offers evidence of the benefits it might bring in terms of protecting cognitive functions and quality of life. We hope this work will lead to more research in this vital area."

For more information: www.estro.org

Related Content

VIDEO: Advancements in Radiation Therapy for Brain Cancer

Hippocampal Sparing Prevents Whole-Brain Radiotherapy Cognitive Side Effects

Advances in Neuro-oncology

Related Content

According to the new market research report "Radiation Dose Management Market by Products & Services (Standalone Solutions, Integrated Solutions, Services), Modality (Computed Tomography, Nuclear Medicine), Application (Oncology, Cardiology, Orthopedic), End User (Hospitals) - Global Forecast to 2025", published by MarketsandMarkets, the radiation dose management market is projected to reach USD 422.65 million by 2025 from USD 220.22 million in 2020, at a CAGR of 13.9%.

Courtesy of MarketsandMarkets Research

News | Radiation Dose Management | August 03, 2020
August 3, 2020 — According to the new market research report "...
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.

Getty Images

News | Radiology Business | August 03, 2020
August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly wel
JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

Table 1. JAMA Oncol. Published online  July 30, 2020. doi:10.1001/jamaoncol.2020.2783

News | Coronavirus (COVID-19) | July 31, 2020
July 31, 2020 — An article published in JAMA...
Older Americans may be receiving cancer screenings not recommended by the U.S. Preventive Services Task Force, according to Penn State College of Medicine researchers.

Getty Images

News | Radiology Imaging | July 31, 2020
July 31, 2020 — Older Americans may be receiving cancer screenings not recommended by the...
It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer deaths in the UK during the next 12 months, and  Zegami, the Oxford University data visualization spin-out which has worked on several projects focused on the detection, diagnosis, or management of cancer, is calling for greater use of technology to speed up the process of diagnosis and treatment.

Getty Images

News | Radiation Oncology | July 29, 2020
July 29, 2020 — It has been estimated that the overwhelming focus on...
Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics

News | Prostate Cancer | July 28, 2020
July 28, 2020 — A study published in 
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510
(a) A schematic of cycloidal computed tomography (not to scale, seen from top); by adding an array of beam stops in front of the detector, the setup is transformed into an edge-illumination x-ray phase-contrast imaging device. (b) A sinogram sampling grid for a rotation-only scheme. (c) A sinogram sampling grid for a cycloidal scheme. The grids are shown for one mask period and a subset of rotation angles; the combination of empty and filled circles shows the grids that would be achieved through fine latera

(a) A schematic of cycloidal computed tomography (not to scale, seen from top); by adding an array of beam stops in front of the detector, the setup is transformed into an edge-illumination x-ray phase-contrast imaging device. (b) A sinogram sampling grid for a rotation-only scheme. (c) A sinogram sampling grid for a cycloidal scheme. The grids are shown for one mask period and a subset of rotation angles; the combination of empty and filled circles shows the grids that would be achieved through fine lateral sampling (requiring dithering); the filled circles show the data that are sampled without dithering.

News | Computed Tomography (CT) | July 24, 2020
July 24, 2020 — A computed tomography (CT) sca